SUCCEED: Engaging Black Men in Colorectal Cancer Screening

Sponsor
Virginia Commonwealth University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05980182
Collaborator
National Cancer Institute (NCI) (NIH)
30
1
1
15
2

Study Details

Study Description

Brief Summary

To determine the unmet needs, attitudes, barriers and facilitators of African American (AA)/ Black men use of colorectal cancer screening and describe how community leaders such as barbers may act as Community Champions to educate and facilitate screening participation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: mHealth Application
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
SUCCEED: Engaging Black Men in Colorectal Cancer Screening (CRC) Screening
Anticipated Study Start Date :
Aug 1, 2023
Anticipated Primary Completion Date :
Oct 31, 2024
Anticipated Study Completion Date :
Oct 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tailored Screen to Save (S2S) content

Content to be delivered using a combination of short video and text-based information optimized for delivery via Quick Response (QR) codes for smartphones.

Behavioral: mHealth Application
Self-directed application (app) that is downloaded to the participant's personal device. The app contains five informational videos, that provide an orientation to the content on the app, and discuss what colorectal cancer is, and the type of CRC screening tests that are available as well as a video with a personal history. There is a a National Cancer Institute (NCI) risk calculation tool, and a family history infographic. Once the videos have been viewed participants have the option to indicate if they wish to receive a call from the healthcare clinic to discuss scheduling an appointment for screening.

Outcome Measures

Primary Outcome Measures

  1. Colorectal Screening Status [3 Months]

    The number of participants that complete screening (any type)

Secondary Outcome Measures

  1. Determine feasibility of Mobile Health (mHealth) Application -Enrollment [Week 1]

    The number of men that enroll for the intervention (application)

  2. Determine the feasibility of the mHealth Application-Videos [Week 1]

    The number of participants that view the videos

  3. Determine the feasibility of the mHealth Application- Retention [Baseline (Day 1), Week 2, and Week 12]

    The number of participants that complete Questionnaires (>75%)

  4. Determine the feasibility of the mHealth Application- Clinic/ Screening Request [Week 12]

    The number of participants that respond to the request to contact clinic/ navigation services

  5. Determine the feasibility of the mHealth Application - Sharing Content [Week 12]

    The number of participants that share content on social network

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 74 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Adult men

  • Identify as Black or African American

  • Work or live in Petersburg, VA or surrounding counties

  • Eligible for colorectal cancer (CRC) screening at time of study enrollment

Exclusion Criteria:
  • Inability to speak or read English

  • Currently up-to-date with CRC screening

Contacts and Locations

Locations

Site City State Country Postal Code
1 Virginia Commonwealth University Richmond Virginia United States 23298

Sponsors and Collaborators

  • Virginia Commonwealth University
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Maria Thomson, Ph.D., Virginia Commonwealt University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT05980182
Other Study ID Numbers:
  • MCC-21-18632
  • HM20023619
First Posted:
Aug 7, 2023
Last Update Posted:
Aug 7, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Virginia Commonwealth University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 7, 2023